<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="Activity\PMC7791836\results\search\disease\results.xml">
  <result pre="has been used to treat colds, nausea, fever, headache, and" exact="diarrhea" post="[1]. Guanghuoxiang is among the raw materials used in"/>
  <result pre="treat gastrointestinal diseases, while Baoji Pian is mainly used for" exact="common cold" post="with summer-heat and dampness syndrome in TCM [2â€&quot;4]. Previous"/>
  <result pre="in adipocytes [14], alleviate ischemia/reperfusion-induced brain injury [15], and prevent" exact="atherosclerosis" post="[16]. Based on previous review, it can be concluded"/>
  <result pre="could suppress adipogenesis and fat accumulation in adipocytes to prevent" exact="obesity" post="[17]. Another study in the same year demonstrated that"/>
  <result pre="via its role in regulating oxidative stress, which contributes to" exact="chronic obstructive pulmonary disease" post="(COPD) [21]. Moreover, other bioactive ingredients such as Î²-PAE,"/>
  <result pre="levels of GSH, SOD, and CAT activities, together with the" exact="suppression" post="of MDA in gastric tissues. Furthermore, PAO exhibited anti-inflammatory"/>
  <result pre="ERK1/2 signaling pathways [51]. Inflammatory bowel disease (IBD) includes both" exact="ulcerative colitis" post="(UC) and Crohnâ€™s disease; both conditions are chronic and"/>
  <result pre="signaling pathways [51]. Inflammatory bowel disease (IBD) includes both ulcerative" exact="colitis" post="(UC) and Crohnâ€™s disease; both conditions are chronic and"/>
  <result pre="of colonic myeloperoxidase (MPO) in the 2,4,6-trinitrobenzenesulfonic acid-induced model of" exact="ulcerative colitis" post="in rats [56]. Likewise, the administration of PA resulted"/>
  <result pre="colonic myeloperoxidase (MPO) in the 2,4,6-trinitrobenzenesulfonic acid-induced model of ulcerative" exact="colitis" post="in rats [56]. Likewise, the administration of PA resulted"/>
  <result pre="and IL-6). The administration of PA also resulted in the" exact="suppression" post="of several anti-inflammatory cytokines, including IL-4 and IL-10. UC-associated"/>
  <result pre="treat colitis. The pharmacological activities of patchouli with respect to" exact="peptic ulcer" post="disease are included in TableÂ 3. Table 3 Pharmacological"/>
  <result pre="in TableÂ 3. Table 3 Pharmacological activities of patchouli on" exact="peptic ulcer" post="Chemical name Animals &amp;amp; pathological model Efficient doses &amp;amp;"/>
  <result pre="doses &amp;amp; administration route Mechanisms References Pogostone SD Rats; Indomethacin-induced" exact="gastric ulcer" post="10, 20 and 40Â mg/kg, oral administration SODâ†‘, GSHâ†‘,"/>
  <result pre="HSP-70â†‘, Bcl-2â†‘, MDAâ†&quot;, Baxâ†&quot; [48, 49] PAO SD Rats; Ethanol-induced" exact="gastric ulcer" post="10, 20 and 40Â mg/kg, oral administration GSHâ†‘, SODâ†‘,"/>
  <result pre="rectal instillation MPOâ†&quot; [56] PA BalB/C mice; dextran sulfate sodium-induced" exact="colitis" post="10, 20 and 40Â mg/kg, oral administration MPOâ†&quot;, TNF-Î±â†&quot;,"/>
  <result pre="RIP3â†&quot;, MLKLâ†&quot;, IDO-1â†&quot;, TPH-1â†&quot;, [57] C57BL/6 mice; dextran sulphate sodium-induced" exact="colitis" post="6.25, 12.5 and 25Â mg/kg, oral administration CYP3A4â†‘, PXR"/>
  <result pre="TNF-Î± â†&quot; [48] Arrow up denotes activation; arrow down denotes" exact="suppression" post="Antimicrobial effect Effect targeting H. pylori H. pylori is"/>
  <result pre="with various gastrointestinal diseases including gastritis, peptic ulcers, and gastric" exact="cancer" post="[60]. Previous research identified bacterial virulence factors that promote"/>
  <result pre="Fig. 3 The pharmacological mechanisms of PA on H. pylori-induced" exact="gastric ulcer" post="Other antimicrobial effect Earlier studies identified numerous antimicrobial activities"/>
  <result pre="and its capacity to alter cell membrane permeability [74]. Acute" exact="otitis media," post="one of the most common diseases in early infancy"/>
  <result pre="disorders including alcoholic fatty liver, hepatitis, hepatic fibrosis, steatosis, and" exact="cirrhosis" post="[86]. Hepatic steatosis has been widely recognized as an"/>
  <result pre="MCP-1â†&quot;, PGE2â†&quot;, NOâ†&quot;, iNOSâ†&quot;, COX-2â†&quot; [103] PO Swiss mice; Zymosan-induced" exact="peritonitis" post="In vivo 100, 200, 300Â mg/kg oral administration Leukocyte"/>
  <result pre="of neutrophilsâ†‘ Note: Arrow up denotes activation; arrow down denotes" exact="suppression" post="Effect on ischemia/reperfusion (I/R) injury I/R injury is associated"/>
  <result pre="TLR4/NF-ÎºB signaling, pretreatment with Î²-PAE also results in a significant" exact="suppression" post="of cellular apoptosis in I/R injury in rats, largely"/>
  <result pre="an aqueous extract of patchouli could overcome the resistance of" exact="endometrial cancer" post="cells to paclitaxel and could likewise promote growth inhibition"/>
  <result pre="aqueous extract of patchouli could overcome the resistance of endometrial" exact="cancer" post="cells to paclitaxel and could likewise promote growth inhibition"/>
  <result pre="also exhibited antitumor effect when targeting cells of the human" exact="lung cancer" post="A549 line both in vitro and in vivo by"/>
  <result pre="exhibited antitumor effect when targeting cells of the human lung" exact="cancer" post="A549 line both in vitro and in vivo by"/>
  <result pre="administration of PA can also inhibit the proliferation of human" exact="leukemia" post="MV4-11 cells and thereby induce their apoptosis; the mechanisms"/>
  <result pre="It is a factor contributing to the condition known as" exact="metabolic syndrome;" post="this condition is exacerbated by environmental factors, including a"/>
  <result pre="other diseases, including NAFLD. NAFLD is a major cause of" exact="liver disease" post="that affectsâ€‰~â€‰30% of the US population [117], and is"/>
  <result pre="can significantly reduce the risk of events associated with major" exact="cardiovascular disease," post="including stroke and coronary heart disease, among others [121]."/>
  <result pre="the risk of events associated with major cardiovascular disease, including" exact="stroke" post="and coronary heart disease, among others [121]. As such,"/>
  <result pre="events associated with major cardiovascular disease, including stroke and coronary" exact="heart disease," post="among others [121]. As such, it is particularly important"/>
  <result pre="immune system mediates both resistance to pathogens and defense against" exact="cancer" post="[122]. Previous research revealed that PA has a positive"/>
  <result pre="nutrients and energy [126], protect us from enteropathogens [127] and" exact="cancer" post="[128], and may even influence brain function and behavior"/>
  <result pre="may be a predisposing factor associated with IBD [130, 131]," exact="obesity" post="[132, 133], and neoplastic disease [134]. The results of"/>
  <result pre="pharmacological targets of these effects remain unknown. Other effects Secretory" exact="otitis media" post="(SOM) includes inflammation of the mucosa of the middle"/>
  <result pre="inflammation has been associated with several serious respiratory diseases, including" exact="acute respiratory distress syndrome" post="and COPD, among others. The administration of PA serves"/>
  <result pre="protect against LPS-induced acute lung injury in mice by the" exact="suppression" post="of TNF-Î±, IL-1Î², and IL-6 synthesis and release, as"/>
  <result pre="are involved in the treatment process. The PA-mediated relief of" exact="peptic ulcer" post="is associated with the activation of PXR signalling pathway,"/>
  <result pre="the NF-ÎºB pathway, the preservation of intestinal barrier integrity, the" exact="suppression" post="of tryptophan catabolism, and the inhibition of cell death"/>
  <result pre="effects associated with PA, for instance, its role in preventing" exact="obesity" post="and promoting analgesia, have attracted significant attention in recent"/>
  <result pre="DDS Dextran sodium sulfate IBS Irritable bowel syndrome IBS-D Diarrhea-predominant" exact="irritable bowel syndrome" post="IEC-6 Intestinal epithelial-6 cells GM Gut microbiota I/R Ischemia/reperfusion"/>
  <result pre="protein 1 CXCL11 Chemokine (C-X-C motif) ligand 11 NAFLD Nonalcoholic" exact="fatty liver disease" post="LPS Lipopolysaccharide TCM Traditional Chinese medicine Publisher's Note Springer"/>
  <result pre="1 CXCL11 Chemokine (C-X-C motif) ligand 11 NAFLD Nonalcoholic fatty" exact="liver disease" post="LPS Lipopolysaccharide TCM Traditional Chinese medicine Publisher's Note Springer"/>
  <result pre="liquid on intestinal mucosal mechanical barrier of rats with postinfectious" exact="irritable bowel syndrome" post="induced by acetic acidEvid Based Comp Alternative Med.20142014218383 3.ZhaoMChenYWangCXiaoWChenSZhangSYangLLiYSystems"/>
  <result pre="Pharmacol20199144810.3389/fphar.2018.0144830687082 4.FengRZLvJQJohnsonAKMontoyaJDBingMThe efficacy and safety of Baoji Tablets for treating" exact="common cold" post="with summer-heat and dampness syndrome: study protocol for a"/>
  <result pre="essential oil of Pogostemon cablin, exhibits anti-tumorigenic activity in human" exact="colorectal cancer" post="cellsInt Immunopharmacol2013161849010.1016/j.intimp.2013.03.03123602914 10.FengXXYuXTLiWJKongSZLiuYHZhangXXianYFZhangXJSuZRLinZXEffects of topical application of patchouli alcohol"/>
  <result pre="oil of Pogostemon cablin, exhibits anti-tumorigenic activity in human colorectal" exact="cancer" post="cellsInt Immunopharmacol2013161849010.1016/j.intimp.2013.03.03123602914 10.FengXXYuXTLiWJKongSZLiuYHZhangXXianYFZhangXJSuZRLinZXEffects of topical application of patchouli alcohol"/>
  <result pre="mice. Brain Research. 2017, DOI: S0006899317305814. 16.WangHTWangZZWangZCWangSMCaiXJSuGHYuanZYPatchouli alcohol attenuates experimental" exact="atherosclerosis" post="via inhibiting macrophage infiltration and its inflammatory responsesBiomed Pharmacother201683930510.1016/j.biopha.2016.08.00527522255"/>
  <result pre="damage in ratsOsong Public Health Res Perspect20134271710.1016/j.phrp.2013.09.00624298443 45.TytgatGNJEtiopathogenetic principles and" exact="peptic ulcer" post="disease classificationDig Dis201129454810.1159/00033152022095009 46.ScheimanJMYeomansNDTalleyNJVakilNChanFKLTulassayZRainoldiJLSzczepanskiLUngKAKleczkowskiDPrevention of ulcers by esomeprazole in"/>
  <result pre="COX-2 inhibitorsAm J Gastroenterol20061017011010.1111/j.1572-0241.2006.00499.x16494585 47.GaoJChangXYWeiTTLuoFJiangWJProtective activity of salidroside against ethanol-induced" exact="gastric ulcer" post="via the MAPK/NF-kappa B pathway in vivo and in"/>
  <result pre="Immunopharmacol2015286041510.1016/j.intimp.2015.07.03126241782 48.ChenHLiaoHLiuYZhengYSuZProtective effects of pogostone from Pogostemonis Herba against ethanol-induced" exact="gastric ulcer" post="in ratsFitoterapia2014100110710.1016/j.fitote.2014.11.01725481373 49.ChenXYChenHMLiuYHZhangZBZhengYFSuZQThe gastroprotective effect of pogostone from Pogostemonis"/>
  <result pre="49.ChenXYChenHMLiuYHZhangZBZhengYFSuZQThe gastroprotective effect of pogostone from Pogostemonis Herba against indomethacin-induced" exact="gastric ulcer" post="in ratsExp Biol Med201624119320410.1177/1535370215600099 50.LiangJDouYWuXLiHWuJHuangQLuoDYiTLiuYSuZProphylactic efficacy of patchoulene epoxide"/>
  <result pre="ratsExp Biol Med201624119320410.1177/1535370215600099 50.LiangJDouYWuXLiHWuJHuangQLuoDYiTLiuYSuZProphylactic efficacy of patchoulene epoxide against ethanol-induced" exact="gastric ulcer" post="in rats: Influence on oxidative stress, inflammation and apoptosisChem"/>
  <result pre="ratsExp Ther Med20171411849210.3892/etm.2017.457728810577 57.QuCYuanZWYuXTHuangYFYangGHChenJNLaiXPSuZRZengHFXieYPatchouli alcohol ameliorates dextran sodium sulfate-induced experimental" exact="colitis" post="and suppresses tryptophan catabolismPharmacol Res2017121708210.1016/j.phrs.2017.04.01728456683 58.ZhangGHLiuMJSongMWangJYCaiJZLinCQLiYWJinXShenCPChenZCaiDKGaoYZhuCCLinCZLiuCHPatchouli alcohol activates PXR"/>
  <result pre="of pogotone against Staphylococcus aureusChinese J Antibiotics20184375964 75.MarCDSandersSLHayemMAntibiotics for acute" exact="otitis media" post="in children2000New JerseyWiley 76.Nokso-KoivistoJMaromTChonmaitreeTImportance of viruses in acute otitis"/>
  <result pre="Opin Pediatr201527110510.1097/MOP.000000000000018425514574 77.TangZWPengCWangPBCaoXYEffect of Pogostemonis Herba oil in treating acute" exact="otitis media" post="model guinea pigsChin J Exp Trad Med Formulae2015211448 78.SchieberMChandelNSROS"/>
  <result pre="in vivoBiomed Res Int.20162164567580 114.YangYTHeBXHeYLPengCXiongLCaoZXPatchouli alcohol induces apoptosis of MV4-11" exact="leukemia" post="cells by PKM2 and NF-ÎºBChin J Exp Traditional Med"/>
  <result pre="Med Formulae20162299103 115.KimKAGuWLeeIAJohEHKimDHHigh fat diet-induced gut microbiota exacerbates inflammation and" exact="obesity" post="in mice via the TLR4 signaling pathwayPLoS One20127e4771310.1371/journal.pone.004771323091640 116.LeeJKongBLeeS-HPatchouli"/>
  <result pre="World Health Organization. 1959. 121.EttehadDEmdinCAKiranAAndersonSGCallenderTEmbersonJChalmersJRodgersARahimiKBlood pressure lowering for prevention of" exact="cardiovascular disease" post="and death: a systematic review and meta-analysisLancet20163879576710.1016/S0140-6736(15)01225-826724178 122.GaiplUSCandeiasSMThe immune"/>
  <result pre="death: a systematic review and meta-analysisLancet20163879576710.1016/S0140-6736(15)01225-826724178 122.GaiplUSCandeiasSMThe immune system in" exact="cancer" post="prevention, development and therapyAnti-Cancer Agents Med Chem Formerly Curr"/>
  <result pre="human gut microbes associated with obesityNature20064441022310.1038/4441022a17183309 134.SobhaniITapJRoudot-ThoravalFRoperchJPLetulleSLangellaPCorthierGVan TranNhieuJFuretJPMicrobial dysbiosis in" exact="colorectal cancer" post="(CRC) patientsPLoS One20116e1639310.1371/journal.pone.001639321297998 135.LeongWHuangGKhanIXiaWHsiaoWLWPatchouli Essential Oil and Its Derived"/>
  <result pre="gut microbes associated with obesityNature20064441022310.1038/4441022a17183309 134.SobhaniITapJRoudot-ThoravalFRoperchJPLetulleSLangellaPCorthierGVan TranNhieuJFuretJPMicrobial dysbiosis in colorectal" exact="cancer" post="(CRC) patientsPLoS One20116e1639310.1371/journal.pone.001639321297998 135.LeongWHuangGKhanIXiaWHsiaoWLWPatchouli Essential Oil and Its Derived"/>
  <result pre="development of zebrafish embryosChinese J Ethnomed Ethnopharm201524146 144.PengFXieXPengCChinese herbal medicine-based" exact="cancer" post="therapy: novel anticancer agents targeting microRNAs to regulate tumor"/>
  <result pre="Chin Med201947817113510.1142/S0192415X1950087331801358 145.PengFXiongLXieXTangHHuangRPengCIsoliquiritigenin derivative regulates miR-374a/BAX axis to suppress triple-negative" exact="breast cancer" post="tumorigenesis and developmentFront Pharmacol20201137810.3389/fphar.2020.0037832296334 146.Zhang X, Li X, Li"/>
  <result pre="Med201947817113510.1142/S0192415X1950087331801358 145.PengFXiongLXieXTangHHuangRPengCIsoliquiritigenin derivative regulates miR-374a/BAX axis to suppress triple-negative breast" exact="cancer" post="tumorigenesis and developmentFront Pharmacol20201137810.3389/fphar.2020.0037832296334 146.Zhang X, Li X, Li"/>
  <result pre="rugosaBMC Complement Altern Med20171719310.1186/s12906-017-1592-828166786 149.NamHHKimJSLeeJSeoYHKimHSRyuSMChoiGMoonBCLeeAYPharmacological effects of Agastache rugosa against" exact="gastritis" post="using a network pharmacology approachBiomolecules.202010.3390/biom1009129832916904 150.ShinDLeeYHuangYHLimHWJangKKimDDLimCJProbiotic fermentation augments the"/>
 </snippets>
</snippetsTree>
